Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial. (2020)

First Author: Van Der Pluijm RW
Attributed to:  MRC Centre for Genomics and Global Health funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(20)30552-3

PubMed Identifier: 32171078

Publication URI: http://europepmc.org/abstract/MED/32171078

Type: Journal Article/Review

Volume: 395

Parent Publication: Lancet (London, England)

Issue: 10233

ISSN: 0140-6736